Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sumant Ramachandra currently holds 260,000 shares of Lyell Immunopharma, Inc. (LYEL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sumant Ramachandra has been a net seller of LYEL stock. They have purchased $0 and sold $6.2M worth of shares.
Sumant Ramachandra's most recent insider trade was on Oct 31, 2024, when they sold 260,000 shares at $0.00 per share.
Sumant Ramachandra serves as Executive at Lyell Immunopharma, Inc. (LYEL). They have executed 29 insider transactions totaling $6.2M over their tenure at the company.
Sumant Ramachandra holds the position of Executive at Lyell Immunopharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Sumant Ramachandra has shown a selling trading pattern, with $0 in total purchases and $6.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Sumant Ramachandra was on Sep 3, 2015, when they sold $20.7M worth of HSP shares. This transaction involved 230,494 shares at $90.00 per share.
Sumant Ramachandra currently owns 260,000 shares of Lyell Immunopharma, Inc. (LYEL), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sumant Ramachandra's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sumant Ramachandra has 29 Form 4 filings on record as an insider at Lyell Immunopharma, Inc..
Set alerts for Sumant Ramachandra and 40,000+ other insiders.